HergünerS, KilinçaslanA, GörkerI, TüzünU. Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases. J Child Adolesc Psychopharmacol, 17:367–369. 2007.
7.
KanoK, ArisakaO. Fluvoxamine and enuresis. J Am Acad Child Adolesc Psychiatry, 39:1464–1466. 2000.
8.
MbakiY, RamageAG. Investigation of the role of 5-HT2 receptor subtypes in the control of the bladder and the urethra in the anaesthetized female rat. Br J Pharmacol, 155:343–356. 2008.
9.
MesarosJD. Fluoxetine for primary enuresis. J Am Acad Child Adolesc Psychiatry, 32:877–878. 1993.
10.
MonjiA, YanagimotoK, YoshidaI, HashiokaS. SSRI-induced enuresis: A case report. J Clin Psychopharmacol, 24:564–565. 2004.
MurrayME. Treatment of enuresis with paroxetine. J Dev Behav Pediatr, 18:435–436. 1997.
13.
OgawaT, SekiS, MasudaH, IgawaY, NishizawaO, KunoS, ChancellorMB, de GroatWC, YoshimuraN. Dopaminergic mechanisms controlling urethral function in rats. Neurourol Urodyn, 25:480–489. 2006.
14.
RamadanIM, KhanAY, WestonWE. Response to SSRI-induced enuresis: A case report. J Clin Psychopharmacol, 26:98–99. 2006.
15.
RamageAG. The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition. Br J Pharmacol, 147,Suppl 2:S120–131. 2006.
16.
RichelsonE. Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance. J Clin Psychiatry, 64,Suppl 13:5–12. 2003.
17.
SprengerD. Sertraline for nocturnal enuresis. J Am Acad Child Adolesc Psychiatry, 36:304–305. 1997.